Background For patients with a high risk of sudden cardiac death, despite the benefits of an implantable cardioverter ...
Background Clinical benefit of percutaneous coronary intervention (PCI) in chronic coronary syndromes (CCS) remains ...
Background Circulatory collapse at hospital arrival represents one of the most severe clinical presentations of ST-segment ...
Objectives Elevated resting heart rate (RHR) predicts mortality in middle-aged and older adults, primarily through ...
Background Postoperative atrial fibrillation (AF) is a common complication after coronary artery bypass grafting (CABG) but ...
Original research: Operational performance of the 2023 World Heart Federation screening criteria for rheumatic heart disease in a high-risk, resource-limited population (8 July, 2026) ...
Objective Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiomyopathy characterised by pathological left ventricular hypertrophy and categorised into obstructive and non-obstructive ...
VA (congestive heart failure, hypertension, age ≥75 years (double weight), diabetes mellitus, previous stroke (double weight) ...
Background Pulmonary hypertension (PH) medical therapies are commonly used as a bridge to balloon pulmonary angioplasty (BPA) in patients with chronic thromboembolic PH (CTEPH) but their effectiveness ...
Background Chronic total occlusion (CTO) often triggers collateral coronary development, yet the relationship between angiographically graded collaterals and myocardial viability remains incompletely ...
Objective To investigate whether aligning exercise timing with chronotype enhances cardiometabolic and sleep-related benefits in sedentary adults with cardiovascular risk factors. Methods In this ...
Background Japanese guidelines recommend a corticosteroid maintenance dose of 5–10 mg/day for cardiac sarcoidosis (CS); however, the optimal dose remains unclear. This study aimed to evaluate the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results